Rush to e-prescribing? Not so fast, say docs

You might want to make a note of this. On paper. Despite all the hoopla surrounding electronically generated prescriptions, e-communications and digitized patient recordkeeping over the past decade, most doctors still prefer to write prescriptions the old fashioned way, by hand, scrawled on a prescription pad and handed to the patient.

The high rate of paper-and-pen prescribing persists despite the fact that more than half of U.S.-based doctors have e-prescribing technology at their fingertips, according to MediScripts. “Until physicians gain comfort with the technology, many will continue to depend on time-trusted, easy-to-use pen and paper,” said CEO Erez Lapsker.

According to a report from Surescripts, the e-prescribing platform and service provider, nearly 36% of U.S. prescriptions dispensed were generated electronically in 2011, and doctors wrote 570 million e-prescriptions. But they wrote 916 million scripts by hand on MediScripts prescription pads alone, not to mention what was written by hand elsewhere. Total number of prescriptions dispensed in 2011 was 4.024 billion, but that includes refills that don’t generate a newly written script, remember.

It should be pointed out that MediScripts, which specializes in delivering targeted promotional messages via prescription pads, has a big dog in this fight. But its point is well taken: that doctors still feel comfortable wheeling across their little examining rooms on their swivel chairs and quickly scribbling out a script for the patient, “without having to fuss with complicated computer software,” to quote the company’s report.

If you’re a licensed pharmacist or a student doing an internship, please share your own experiences by clicking on the comment link. How much of an impact is e-prescribing having in your practice setting? Are paper scripts still the norm where you dispense, verify and counsel?

Amneal ships opioid-dependence drug

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has started shipping a drug used to treat opioid dependence, the company said Tuesday.

The generic drug maker announced the shipment of buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets in the 2-mg/0.5-mg and 8-mg/2-mg strengths. The Food and Drug Administration approved the drug in February.

The drug includes a risk evaluation and mitigation strategy, or REMS, a program required by the FDA to ensure that its benefits outweigh its risks.

The drug is a generic version of Reckitt Benckiser Healthcare’s Suboxone, which had sales of $1.5 billion in 2012, according to IMS Health.

As part of a panel at the recent Drug Store News Industry Issues Summit, officials from Walmart and Kroger shared the ways the two organizations go about taking a collaborative approach to health care.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry